. The frequency of pupariation is increased upon exposure of tumour-bearing larvae to PD0325901. The percentage of Ras V12 scrib 1 tumour-bearing larvae to have pupated at day 9 was determined after 5 days exposure to either carrier alone (DMSO, 0.5%) or MEK inhibitor (final concentration, 50 mM) (one way ANOVA, * P < 0.0001; n = 8 wells; error bars, s.e.m).
Fig. S2.
Idarubicin inhibits tumour development. Quantification of GFP-positive pixel counts (A: t-test, P<0.0001; n = 6; error bars, s.e.m), and pupariation frequencies (B: t-test, P < 0.0001; n = 4; error bars, s.e.m) of 9-day-old larvae, bearing GFP-labelled Ras V12 scrib 1 tumours, after 5 days exposure to either carrier alone (DMSO, 0.5%) or 50 mM idarubicin. . Acivicin inhibits tumour development in a dose-dependent manner. Quantification of pixel counts after larvae bearing GFP-labelled Ras V12 scrib 1 tumours were exposed for 5 days to carrier alone (DMSO, 0.5%) or 0.5mM to 50mM acivicin (one way ANOVA, * P < 0.01, ** P < 0.0001; n = 8 wells; error bars, s.e.m). Representative well images of these data in binarised GFP and white light are shown below.
Fig. S6
. Notch-driven tumours are responsive to acivicin-mediated inhibition, but not inhibition by the MEK inhibitor PD0325901. The tumour-bearing larvae were generated from crossing UAS-N intra ; FRT82B,scrib 1 /TM6B male flies to ey-FLP,UAS-GFP; ; Tub-Gal4,FRT82B,Tub-Gal80/TM6B females, and treated for 5 days, as described for Ras V12 scrib 1 larvae. (A) Quantification of pixel counts after 5 days exposure of N intra scrib 1 tumour-bearing larvae to carrier alone (DMSO, 0.5%), 50mM acivicin or 50mM PD0325901 (one way ANOVA, P < 0.0001; n = 8 wells; error bars, s.e.m). (B) Quantification of pupariation frequencies for N intra scrib 1 tumour-bearing larvae upon exposure to 50mM acivicin (t-test, P < 0.0001; n = 8 wells; error bars, s.e.m). S8 . Exposure of tumour-bearing larvae to amino-oxyacetic acid (AOA) reduces tumour overgrowth. Quantification of pixel counts after larvae bearing GFP-labelled Ras V12 scrib 1 tumours were treated with carrier alone (DMSO, 0.5%), 50mM acivicin, or 400mM AOA (t-test, * P < 0.0001; n = 4 wells; error bars, s.e.m). Larvae were exposed to fresh chemical daily, over a 9 day period, using the same exposure regime described for the treatment of transplanted adult flies. Fig. S9 . The Z-prime factor calculated from pixel counts, using acivicin as a positive control. Four-day-old larvae bearing GFP-labelled Ras V12 scrib 1 tumours were grown in 96 well plate format (seven larvae per well) in either carrier alone (DMSO, 0.5%) or 50mM acivicin. After five days exposure, the pixel counts per larva were determined for the two conditions (t-test, P < 0.0001; n = 48 wells; error bars, s.d). The Z-prime factor is a measure of how clearly the means of positive and negative controls (ie. the signal-to-background window) are separated with respect to their standard deviations, and was calculated using the formula: Z-prime = 1 -(3 s.d of positive control + 3 s.d of negative control/|mean of positive control -mean of negative control|) (Zhang et al., 1999) . Chemicals were first dissolved in DMSO to make stock solutions, and these were assayed for their toxicity by exposing w 1118 larvae to increasing concentrations of the chemical in standard fly food.
Chemicals were considered to be toxic if all larvae died prior to the onset of pupariation. The efficacy of the chemical against tumour formation in the tumour-bearing larvae was then determined in standard fly food at a drug concentration either just below toxicity, or if the drug was not toxic, at the highest concentration tested. Larvae were exposed to the drug from the early 1 st instar stage of development (day 2), and drug efficacy was determined at day 10 by the extent of GFP-tumour burden. Note that exposure of 2-day-old tumour-bearing larvae to 50µM idarubicin was toxic to the larvae, although exposure of 4-day-old larvae to 50µM idarubicin (as in Fig. S2) increases pupariation.
